The Efficacy and Safety of PEG-rhG-CSFPegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2017
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 02 Nov 2016 New trial record